Evidence map›Paper›PMID 40498077›Full record

ArticleNucleic acids research2025

KIF2C condensation concentrates PLK1 and phosphorylated BRCA2 on kinetochore microtubules in mitosis.

Anastasiia Skobelkina, Manon Julien, Sylvain Jeannin, Simona Miron, Tom Egger, Rady Chaaban, Guillaume Bouvignies, Emile Alghoul, Rania Ghouil, Claire Friel and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Anastasiia SkobelkinaInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Manon JulienInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Sylvain JeanninInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.ORCID 0009-0009-2483-4425
Simona MironInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Tom EggerIGH, Univ Montpellier, CNRS, 34090 Montpellier, France.
Rady ChaabanGenome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.
Guillaume BouvigniesLaboratoire des Biomolécules, LBM, Département de chimie, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, 75005 Paris, France.
Emile AlghoulIGH, Univ Montpellier, CNRS, 34090 Montpellier, France.
Rania GhouilInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Claire FrielSchool of Life Sciences, University of Nottingham, Medical School, QMC, Nottingham NG7 2UH, United Kingdom.
Didier BussoCIGEx, Université Paris Cité et Université Paris-Saclay, INSERM, CEA, Genetic Stability, Stem Cells and Radiation, 92260 Fontenay-aux-Roses, France.
Juan C CañasGenome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.
François-Xavier TheilletInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Romain Le BarsInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
Aura CarreiraGenome Instability and Cancer Predisposition Laboratory, Centro de Biologia Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid 28049, Spain.ORCID 0000-0001-5489-4343
Angelos ConstantinouIGH, Univ Montpellier, CNRS, 34090 Montpellier, France.
Jihane BasbousIGH, Univ Montpellier, CNRS, 34090 Montpellier, France.ORCID 0000-0002-3943-627X
Sophie Zinn-JustinInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.ORCID 0000-0002-7680-1088

Funding

ANR ANR-21-CEA13-0030ARC N°248989Asociacion Española contra el Cancer (AECC) PRYGN234480CARRCEACEA-SaclayCNRSFondation MSD AVENIRFrench Agence Nationale de la Recherche ANR AAPG2021French Agence Nationale de la Recherche ANR AAPG2023French Infrastructure for Integrated Structural Biology ANR-10-INSB-05-01French National Cancer Institute INCa PLBIO 2021FRM N°FDT202304016927I'Agence Nationale de la Recherche FBI ANR-24-INBS-0005I'Agence Nationale de la Recherche SPS ANR-17-EUR-0007INSERM PCSI 2022IR INFRANALYTICS FR2054PSL University FellowshipSynchrotron SOLEIL
6 · The paper itself

Abstract

During mitosis, the microtubule depolymerase KIF2C, the tumor suppressor BRCA2, and the kinase PLK1 contribute to the control of kinetochore-microtubule attachments. Both KIF2C and BRCA2 are phosphorylated by PLK1, and BRCA2 phosphorylated at T207 (BRCA2-pT207) serves as a docking site for PLK1. Reducing this interaction results in unstable microtubule-kinetochore attachments. Here we identified that KIF2C also directly interacts with BRCA2-pT207. Indeed, the N-terminal domain of KIF2C adopts a Tudor/PWWP/MBT fold that unexpectedly binds to phosphorylated motifs. Using an optogenetic platform, we found that KIF2C forms membrane-less organelles that assemble through interactions mediated by this phospho-binding domain. KIF2C condensation does not depend on BRCA2-pT207 but requires active Aurora B and PLK1 kinases. Moreover, it concentrates PLK1 and BRCA2-pT207 in an Aurora B-dependent manner. Finally, KIF2C depolymerase activity promotes the formation of KIF2C condensates, but strikingly, KIF2C condensates exclude tubulin: they are located on microtubules, especially at their extremities. Altogether, our results suggest that, during the attachment of kinetochores to microtubules, the assembly of KIF2C condensates amplifies PLK1 and KIF2C catalytic activities and spatially concentrates BRCA2-pT207 at the extremities of microtubules. We propose that this novel and highly regulated mechanism contributes to the control of microtubule-kinetochore attachments, chromosome alignment, and stability.

Indexed as

BRCA2 ProteinCell Cycle ProteinsKinesinsKinetochoresMicrotubulesMitosisProtein Serine-Threonine KinasesProto-Oncogene ProteinsAurora Kinase BHeLa CellsHumansPhosphorylationPolo-Like Kinase 1Protein BindingAURKB protein, humanAurora Kinase BBRCA2 ProteinBRCA2 protein, humanCell Cycle ProteinsKIF2C protein, humanKinesinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene Proteins

Identifiers

PMID40498077
PMCPMC12153341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.